HLA believe they can comfortably acquire $2.5m of EBITDA every year on attractive multiples. So far they are half way towards their target for FY19. My best guess is that they will announce new acquisitions some time this month and maybe another lot around May/June. As they build a track record of acquisitions and modest organic growth I can see them replicating the early days of GXL. Or at least that is the plan.
HLA Price at posting:
96.5¢ Sentiment: None Disclosure: Held
